CARL L GORDON Transaction History

Date Transaction Value Shares Traded Form
Apr 03 2024
SELL
Sale (or disposition) back to the issuer
-
8,009,729
May 05 2023
BUY
Open market or private purchase
$2,766,484 $2.82 p/Share
981,023
May 04 2023
BUY
Open market or private purchase
$1,319,749 $2.75 p/Share
479,909
May 02 2023
BUY
Open market or private purchase
$903,159 $2.67 p/Share
338,262
May 01 2023
BUY
Open market or private purchase
$1,876,331 $2.62 p/Share
716,157
Apr 28 2023
BUY
Open market or private purchase
$894,409 $2.55 p/Share
350,749
Feb 17 2023
BUY
Grant, award, or other acquisition
-
1,100,000
Feb 15 2022
BUY
Open market or private purchase
$89,640 $9.96 p/Share
9,000
Feb 14 2022
BUY
Open market or private purchase
$305,158 $9.94 p/Share
30,700
Feb 11 2022
BUY
Open market or private purchase
$1,594,320 $10.22 p/Share
156,000
Dec 07 2020
BUY
Conversion of derivative security
-
3,097,929
Dec 02 2020
BUY
Open market or private purchase
$15,000,000 $20.0 p/Share
750,000

Also insider at

TPTX
Turning Point Therapeutics, Inc.
PRVL
Prevail Therapeutics Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

Director
San Diego, CA

Track Institutional and Insider Activities on KNTE

Follow Kinnate Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNTE shares.

Notify only if

Insider Trading

Get notified when an Kinnate Biopharma Inc. insider buys or sells KNTE shares.

Notify only if

News

Receive news related to Kinnate Biopharma Inc.

Track Activities on KNTE